The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Open accessAbstract
BACKGROUND: The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevated in pregnant women before the clinical onset of preeclampsia, but its predictive value in women with suspected preeclampsia is unclear. METHODS: We performed a prospective, multicenter, observational study to derive and validate a ratio of serum sFlt-1 to PlGF that would be predictive of the absence or presence of preeclampsia in the short term in women with singleton pregnancies in whom preeclampsia was suspected (24 weeks 0 days to 36 weeks 6 days of gestation). Primary objectives were to assess whether low sFlt-1:PlGF ratios (at or below a derived cutoff) predict the absence of preeclampsia within 1 week after the first visit and whether high ratios (above the cutoff) predict the presence of preeclampsia within 4 weeks. RESULTS: In the development cohort (500 women), we identified an sFlt-1:PlGF ratio cutoff of 38 as having important predictive value. In a subsequent validation study among an additional 550 women, an sFlt-1:PlGF ratio of 38 or lower had a negative predictive value (i.e., no preeclampsia in the subsequent week) of 99.3% (95% confidence interval [CI], 97.9 to 99.9), with 80.0% sensitivity (95% CI, 51.9 to 95.7) and 78.3% specificity (95% CI, 74.6 to 81.7). The positive predictive value of an sFlt-1:PlGF ratio above 38 for a diagnosis of preeclampsia within 4 weeks was 36.7% (95% CI, 28.4 to 45.7), with 66.2% sensitivity (95% CI, 54.0 to 77.0) and 83.1% specificity (95% CI, 79.4 to 86.3). CONCLUSIONS: An sFlt-1:PlGF ratio of 38 or lower can be used to predict the short-term absence of preeclampsia in women in whom the syndrome is suspected clinically. (Funded by Roche Diagnostics.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and causes of preterm birth
Goldenberg, R. L., Culhane, J. F., Iams, J. D., & Romero, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60074-4 · Cited by 7,801
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
The Global Impact of Pre-eclampsia and Eclampsia
Duley, L. (2009) · Seminars in Perinatology · doi:10.1053/j.semperi.2009.02.010 · Cited by 2,866
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Brown, M. A., Lindheimer, M. D., Swiet, M. D., Assche, A. V., & Moutquin, J.-M. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
Levine, R. J., Lam, C., Qian, C., Yu, K. F., Maynard, S. E., Sachs, B. P., Sibai, B. M., Epstein, F. H., Romero, R., Thadhani, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055352 · Cited by 1,802
Kendall, R. L., & Thomas, K. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10705 · Cited by 1,394
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
(2006) · New England Journal of Medicine · doi:10.1056/nejmx060063 · Cited by 1,235
Pre-eclampsia part 1: current understanding of its pathophysiology
Chaiworapongsa, T., Chaemsaithong, P., Yeo, L., & Romero, R. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.102 · Cited by 956
Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis
Ananth, C. V., Keyes, K. M., & Wapner, R. J. (2013) · BMJ · doi:10.1136/bmj.f6564 · Cited by 940
Subclassification of Preeclampsia
von Dadelszen, P., Magee, L. A., & Roberts, J. M. (2003) · Hypertension in Pregnancy · doi:10.1081/prg-120021060 · Cited by 763
Diagnosis and management of preeclampsia and eclampsia
(2002) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(02)80002-9 · Cited by 703
Romero, R., Nien, J. K., Espinoza, J., Todem, D., Fu, W., Chung, H., Kusanovic, J. P., Gotsch, F., Erez, O., Mazaki-Tovi, S., et al. (2008) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050701830480 · Cited by 675
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia
Rana, S., Powe, C. E., Salahuddin, S., Verlohren, S., Perschel, F. H., Levine, R. J., Lim, K.-H., Wenger, J. B., Thadhani, R., & Karumanchi, S. A. (2012) · Circulation · doi:10.1161/circulationaha.111.054361 · Cited by 668
Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study
Hernandez-Diaz, S., Toh, S., & Cnattingius, S. (2009) · BMJ · doi:10.1136/bmj.b2255 · Cited by 566
Henderson, J. T., Whitlock, E. P., O’Connor, E., Senger, C. A., Thompson, J. H., & Rowland, M. G. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2844 · Cited by 499
Chappell, L. C., Duckworth, S., Seed, P. T., Griffin, M., Myers, J., Mackillop, L., Simpson, N., Waugh, J., Anumba, D., Kenny, L. C., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003215 · Cited by 496
Verlohren, S., Herraiz, I., Lapaire, O., Schlembach, D., Moertl, M., Zeisler, H., Calda, P., Holzgreve, W., Galindo, A., Engels, T., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.07.037 · Cited by 448
Self-citationThe Interval between Pregnancies and the Risk of Preeclampsia
Skjærven, R., Wilcox, A. J., & Lie, R. T. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011379 · Cited by 429
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia
Verlohren, S., Galindo, A., Schlembach, D., Zeisler, H., Herraiz, I., Moertl, M. G., Pape, J., Dudenhausen, J. W., Denk, B., & Stepan, H. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.09.016 · Cited by 428
Self-citationRedefining Preeclampsia Using Placenta-Derived Biomarkers
Staff, A. C., Benton, S. J., von Dadelszen, P., Roberts, J. M., Taylor, R. N., Powers, R. W., Charnock-Jones, D. S., & Redman, C. W. G. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00250 · Cited by 372
Self-citationVerlohren, S., Herraiz, I., Lapaire, O., Schlembach, D., Zeisler, H., Calda, P., Sabria, J., Markfeld-Erol, F., Galindo, A., Schoofs, K., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.01787 · Cited by 372
Self-citationPrevention of Preterm Delivery
Simhan, H. N., & Caritis, S. N. (2007) · New England Journal of Medicine · doi:10.1056/nejmra050435 · Cited by 292
Sequential Changes in Antiangiogenic Factors in Early Pregnancy and Risk of Developing Preeclampsia
Rana, S., Karumanchi, S. A., Levine, R. J., Venkatesha, S., Rauh-Hain, J. A., Tamez, H., & Thadhani, R. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.087700 · Cited by 286
Xu, Q., Liang, Y., & Du, Y. (2004) · Journal of Chemometrics · doi:10.1002/cem.858 · Cited by 235
Lu, F., Longo, M., Tamayo, E., Maner, W., Al-Hendy, A., Anderson, G. D., Hankins, G. D. V., & Saade, G. R. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.12.024 · Cited by 224
Prediction of adverse outcomes by common definitions of hypertension in pregnancy
Zhang, J. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)01125-x · Cited by 188
Angiogenic factors for the prediction of preeclampsia in high-risk women
Moore Simas, T. A., Crawford, S. L., Solitro, M. J., Frost, S. C., Meyer, B. A., & Maynard, S. E. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.06.030 · Cited by 185
Vatten, L. J., Eskild, A., Nilsen, T. I. L., Jeansson, S., Jenum, P. A., & Staff, A. C. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.10.909 · Cited by 182
Self-citationTwelve Steps to Optimal Management of HELLP Syndrome
MAGANN, E. F., & MARTIN, J. N. (1999) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-199909000-00009 · Cited by 169
Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006–8: a review
McClure, J. H., COOPER, G. M., & Clutton-Brock, T. H. (2011) · British Journal of Anaesthesia · doi:10.1093/bja/aer192 · Cited by 125
Placental ischemia and soluble fms-like tyrosine kinase 1: Cause or consequence of preeclampsia?
Karumanchi, S. A., & Epstein, F. H. (2007) · Kidney International · doi:10.1038/sj.ki.5002281 · Cited by 97
Hund, M., Allegranza, D., Schoedl, M., Dilba, P., Verhagen-Kamerbeek, W. D. J., & Stepan, H. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-324 · Cited by 97
Self-citationChaiworapongsa, T., Romero, R. J., Korzeniewski, S. J., Cortez, J. M., Pappas, A., Tarca, A. L., Chaemsaithong, P., Dong, Z., Yeo, L., & Hassan, S. S. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.806905 · Cited by 88
Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort
Villa, P., Hämäläinen, E. K., Mäki, A., Räikkönen, K., Pesonen, A., Taipale, P., Kajantie, E., & Laivuori, H. M. (2013) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-13-110 · Cited by 84
Moore, A. G., Young, H. A., Keller, J. M., Ojo, L., Yan, J., Simas, T. A. M., & Maynard, S. E. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.713055 · Cited by 76
Lai, J., Garcia-Tizon Larroca, S., Peeva, G., Poon, L. C., Wright, D., & Nicolaides, K. H. (2014) · Fetal Diagnosis and Therapy · doi:10.1159/000359968 · Cited by 63
New biomarkers in diagnosis of early onset preeclampsia and imminent delivery prognosis
Álvarez-Fernández, I., García, B. P., Rodríguez, V., Ruano, Y., Escudero, A. I., & Álvarez, F. V. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0901 · Cited by 62
Holmes, V. A., Young, I. S., Patterson, C., Maresh, M., Pearson, D. W. M., Walker, J. D., McCance, D. R., & for the Diabetes and Preeclampsia Intervention Trial (DAPIT) Study Group (2013) · Diabetes Care · doi:10.2337/dc13-0944 · Cited by 34
Cited by
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
Rana (2019) · doi:10.1161/circresaha.118.313276 · Cited by 2,095
Metadata
- Authors
- Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M., Brennecke, S. P., Stepan, H., Allegranza, D., Dilba, P., Schoedl, M., Hund, M., & Verlohren, S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-01-07
- Volume
- 374
- Issue
- 1
- Pages
- 13-22
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2233974801
- Cited by
- 1,783
- References
- 41
- FWCI
- 187.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.